Skip to main content
Premium Trial:

Request an Annual Quote

European Court Sides With Oxford Gene Technology in Patent Dispute

NEW YORK, Nov. 23 - The European Patent Office has sided with Oxford Gene Technology after a six-year patent dispute the chip company filed against a number of microarray, biotech, and pharmaceutical firms, OGT said on Friday.


Seven companies, including Affymetrix, Abbott Laboratories, Roche Holding, and Nanogen, originally opposed the patent, which was granted to OGT by the EPO in 1994. Affy withdrew after settling with ODG in March.


Ed Southern, owner of UK-based OGT and the patent's inventor, said the decision "greatly strengthens the patent, and we intend to pursue the many licensing opportunities with renewed determination."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.